What We DO and DON’T like about the proposed CPH Merger

Today Creso Pharma (ASX: CPH | OTC: COPHF) announced its plans to merge with a Canadian listed psychedelics company called Red Light Holland.

The CPH Share Price Seems to Have Stabilised – What’s Next?

Today Creso Pharma (ASX: CPH) reported new and follow up Purchase Orders for its animal health medicinal cannabis products totalling over A$345,000.

Scandinavian Sales Agreement Expands Creso Pharma’s European Footprint

Creso Pharma Limited (ASX:CPH, FRA:1X8) has signed a commercial term sheet agreement with Farmagon, Oslo, Norway to enter the Scandinavia market with Creso products.

CPH Set to Expand cannaQIX® Product Line After Major Technological Breakthrough

Hot on the heels of major developments in human and animal health, Creso Pharma (ASX:CPH) has achieved another key milestone: a technological breakthrough that will expand its cannaQIX® human health product line,

CPH Delivers Over 3 Million Anibidiol Doses to Europe's Dogs

Momentum has been building over the last couple of months as CresoPharma (ASX:CPH) outlined its strategy for generating substantial growth in 2020.

Can New Cannabis Products Launch Creso Pharma Higher in 2020?

Through partnerships with leading global companies, Creso Pharma (ASX:CPH) has been able to, and will continue to accelerate the development and distribution of its products worldwide.

Canada Legalises Cannabis as CPH Moves Front and Centre With a 100% Owned Canadian Growing Facility

This week, Canada has become the second country in the world — and the first industrialised nation — to legalise recreational cannabis use nationwide. ASX cannabis innovator, Creso Pharma (ASX:CPH), has welcomed this change with open arms.

CPH has a Thirst for Bringing its Branded Cannabis Lifestyle Products to the World

Creso Pharma (ASX:CPH) is one step closer to launching its range of cannabis infused products.

MXC Moves Towards Commercial-Scale Pot Production with GMP Manufacturing Licence

Nimble ASX pot-stock MGC Pharmaceuticals (ASX:MXC) this week smashed a pivotal milestone, scoring full manufacturing licence for its world-class European compounding and manufacturing facility for the production of euGMP grade medicinal cannabis products.

CPH Continues to Expand Global Footprint As it Moves Into Israeli Cannabis Market

Creso Pharma (ASX:CPH) has today informed the market that it has entered into a joint venture with Cohen Propagation Nurseries Limited to operate a high quality medicinal cannabis growing facility in Israel.

MXC to Build Malta Production Facility to Capitalise on $55B Global Pot Market

MGC Pharmaceuticals (ASX:MXC) has wasted no time ramping up its game in 2018.

CPH Gets Green Light to Distribute its Innovative CBD Based Nutraceutical Products in the UK

While much of the business world shut down over the Christmas-New Year’s break, diversified cannabis healthcare company Creso Pharma (ASX:CPH) has been busy on a number of fronts.

CPH Seal Swiss Pharma Deal: Setting the Cornerstone for Global Commercialisation of cannaQIX

It has been a major month for Creso Pharma (ASX:CPH) as it continues to make potentially market moving announcements.

Budding ASX Junior Pens Transformative Medical Cannabis Deals: Now Generating Revenue

MGC Pharmaceuticals (ASX:MXC) was the second company to originally emerge in the ASX cannabis corridor, and with a whip-smart team that’s put in serious hours in the industry-leading Israeli medicinal marijuana scene, this ASX junior is rapidly coming into its own.

CPH to Acquire Canadian Cannabis Grower and Strengthen Position in Multi-Billion Dollar Market

Creso Pharma (ASX:CPH) is now in the box seat to acquire 100% of Canadian-based Mernova Medicinal Inc., an acquisition that would position CPH as a Canadian producer of legal cannabis.

CPH Signs Exclusive Cannapharm deal: On Track for 2017 Product Release

News of $100 million IPOs, alongside an avalanche of parallel legislative changes around the world, builds a strong case for the burgeoning medicinal marijuana industry. With so many medicinal cannabis stocks fighting for market share and threatening to steal the limelight, a company such as Creso Pharma Ltd (ASX: CPH) needs to do all it can to stay current and competitive.

CPH Deliver Australia’s First Medicinal Cannabis Shipment Under New Legislation

Creso Pharma (ASX: CPH) has made a shipment of medicinal cannabis into Australia – the first import into the country under new government legislation. Under an agreement between CPH and its Australian partner, Health House International Pty Ltd, the pair will distribute a range of cannabis oil products across Australian pharmacies, in compliance with Federal and State legislation.

Medical Marijuana Stock CPH Plants First Seeds in $800M Brazilian Market

There is no doubt about it – medical marijuana stocks are lighting up the ASX right now, as the mainstream media and investment community at large is finally starting to pick up on what we have been saying for over 12 months now.

Are you a sophisticated investor?
Find out more
Please note: Raisebook is a related entity of S3 Consortium Pty Ltd as defined in Section 9 of the Corporations Act 2001.

Thanks for subscribing!